e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Airway regulation and response I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus
R. J. Riese, J. G. Teeter, R. D. England (New London, United States Of America)
Source:
Annual Congress 2005 - Airway regulation and response I
Session:
Airway regulation and response I
Session type:
Thematic Poster Session
Number:
3731
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. J. Riese, J. G. Teeter, R. D. England (New London, United States Of America). Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus. Eur Respir J 2005; 26: Suppl. 49, 3731
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Insulin therapy increases airway responsiveness in type 2 diabetes patients
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus>
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Effect of inhaled human insulin (EXUBERA®; EXU)
vs
subcutaneous insulin (SC) on lung lining fluid constituents in adults with type 1 diabetes mellitus (T1DM)
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007
Development of diabetes mellitus in patients with bronchial asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Long-term use of inhaled corticosteroids and the risk of type 2 diabetes in COPD
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Risk of development of diabetes mellitus in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006
Respiratory muscle function in type 2 diabetes mellitus
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin
Source: Eur Respir J 2004; 24 : 552-558
Year: 2004
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012
Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008
Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2)
Source: Annual Congress 2010 - COPD: management
Year: 2010
Risks of diabetes mellitus and hyperglycaemic adverse events in patients with asthma taking inhaled corticosteroids
Source: Annual Congress 2011 - Asthma management and response
Year: 2011
Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients
Source: Eur Respir J 2007; 30: Suppl. 51, 365s
Year: 2007
Risks of diabetes mellitus and hyperglycaemic adverse events in patients with COPD taking inhaled corticosteroids
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011
Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept